Pharmacy Groups Praise PBM Reform Legislation but Call for More

By Fran KritzIn February, President Trump signed the Consolidated Appropriations Act, 2026, which included significant pharmacy benefit manager (PBM) reforms in the Medicare Part D, Medicare Advantage-Prescription Drug (MA-PD), and commercial markets. Pharmacy associations have expressed support for the step but emphasize the need for further action.figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-align: center; font-size:10px; lin